• G-1: Selective GPR30 Agonist Guide

  2026-09-19

  A practical, scenario-based guide to using G-1 (CAS 881639-98-1), a selective GPR30 agonist, in viability, proliferation, migration, and cytotoxicity workflows. It covers receptor-specific interpretation, DMSO handling, protocol controls, cross-domain evidence, and vendor-selection considerations for SKU B5455.

• Carbapenemase Gene Transmission in CREC

  2026-09-18

  Chen et al. characterize carbapenemase-encoding genes in 54 carbapenem-resistant Enterobacter cloacae isolates from eight Guangdong teaching hospitals, integrating gene localization, conjugation, mobile-element analysis, and ERIC-PCR genotyping. The study shows frequent plasmid-associated blaNDM-1, multidrug resistance, and substantial in vitro transferability, while also defining important limits for interpreting hospital transmission.

• BODIPY 581/591 C11 for Osteoblast Ferroptosis

  2026-09-18

  Build a quantitative lipid peroxidation assay around the red-to-green spectral shift of BODIPY 581/591 C11. The workflow connects live-cell oxidative stress measurement with NRF2/FSP1 biology, helping distinguish membrane lipid oxidation from broader reactive oxygen species signals.

• PPACK Dihydrochloride: A Causal Assay Tool

  2026-09-17

  PPACK Dihydrochloride enables high-affinity, irreversible thrombin inhibition for mechanistic platelet and coagulation studies. This guide shows how to use it as a causal probe alongside NF449 to separate thrombin-dependent signaling from platelet P2X1 activity.

• Cell Integrity Limits Ploidy in Budding Yeast

  2026-09-17

  Barker, Murray, and Bell used two endoreplication strategies in Saccharomyces cerevisiae to define how far ploidy can increase without cell division. Their results identify cell-surface integrity, shaped by growth-associated physical stress, as a major constraint and connect high ploidy with repression of ergosterol-biosynthesis genes.

• LNP-mRNA Fibroblasts for Disc Degeneration

  2026-09-16

  The reference study develops fibroblasts engineered with lipid nanoparticle mRNA to deliver TNF-α antibodies within the inflammatory environment of degenerated intervertebral discs. In cell and rat models, this combined cell-and-mRNA strategy reduced inflammatory injury, preserved extracellular matrix activity, and improved disc height compared with unmodified fibroblasts.

• 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine

  2026-09-16

  This DMSO-soluble α2-adrenergic receptor agonist supports receptor-signaling assays, immune rejection modulation, and post-surgery osteosarcoma recurrence treatment research. A practical workflow links compound handling with orthogonal tumor-cell, immune, proteomic, and hydrogel readouts.

• DEV VP26 Links Actin–Myosin II to Viral Replication

  2026-09-15

  The reference study combines VP26 interactomics with cytoskeletal perturbation to identify the host actin–myosin II network as a regulator of duck enteritis virus proliferation. Its strongest mechanistic evidence centers on MYH9, while pharmacological inhibition and gene silencing provide complementary strategies for testing cytoskeleton-dependent viral processes.

• From Barrier Biology to Faster Allele Genotyping

  2026-09-15

  Mechanistic studies of Lactobacillus gasseri, NR1I3, and E-cadherin show why genotype-aware experimental design matters in translational biology. This thought-leadership guide connects that biology to faster, lower-contamination PCR workflows using the Genotyping Kit for target alleles of insects, tissues, fishes and cells.

• Chloramphenicol: Reliable Plasmid Selection

  2026-09-14

  Learn how Chloramphenicol (SKU A2512) can support reproducible plasmid selection, transmission workflows, and assay interpretation while limiting confounding effects in cell-based experiments. The article combines product specifications with practical controls and recent evidence on resistance-gene mobility.

• Dual-Action Control of p38α MAPK Dephosphorylation

  2026-09-14

  A 2024 preprint shows that selected p38α MAPK inhibitors can do more than block ATP-site catalysis: they can also accelerate WIP1-mediated dephosphorylation of the kinase activation loop. Structural data connect this effect to an inhibitor-stabilized, phosphatase-accessible conformation, suggesting a new design principle for selective kinase inhibition.

• Liproxstatin-1 HCl: Ferroptosis Assay Workflows

  2026-09-13

  Build a controlled ferroptosis assay around Liproxstatin-1 HCl, using lipid-peroxidation rescue, pathway-selective controls, and formulation safeguards. The workflow also connects cellular experiments with mitochondrial calcium–GPX4 biology and preclinical acute renal failure or hepatic ischemia/reperfusion injury models.

• Syringin: Mechanism and RCC Research Workflow

  2026-09-12

  Syringin is a phenylpropanoid glycoside used in natural product research and bioactive compound screening. A 2024 cell-based study associated Syringin with reduced renal cell carcinoma phenotypes, increased apoptosis, and enhanced sunitinib sensitivity through EGFR/PI3K/Akt signaling.

• EPZ5676: Practical DOT1L Inhibitor Workflows

  2026-09-11

  EPZ5676 combines subnanomolar DOT1L potency with strong methyltransferase selectivity, making it useful for connecting biochemical inhibition to H3K79 methylation and leukemia-cell phenotypes. This guide translates that profile into reproducible enzyme, chromatin, and MLL-rearranged leukemia workflows, with practical controls and troubleshooting advice.

• Hydroxychloroquine Sulfate Workflow Guide

  2026-09-11

  Hydroxychloroquine Sulfate (SKU B4874) provides an aqueous-compatible research reagent for investigating autophagy pathway modulation and TLR7/9-dependent immune signaling in autoimmune disease research. It is suited to short-term cell and animal-model workflows, but not to protocols requiring DMSO or ethanol solubility or prolonged storage of prepared solutions.

7997 records 1/534 page Next 12345 下5页 Last page